Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by α-adrenergic receptor antagonists

H. Ono, A. Mishima, S. Ono, H. Fukuda, Michael Vasko

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Effects of clonidine and tizanidine, which have antinociceptive and α2-agonistic actions, were studied on the release of substance P from slices of spinal cord from the rat. Veratridine-evoked depolarization induced a 2-3-fold increase in the release of substance P from the slices of spinal cord. Exposure of the cord tissue to 10 μM clonidine and tizanidine significantly reduced the release of substance P. The inhibitory effects of clonidine and tizanidine were attenuated by pre-exposure of the tissue to 10 μM piperoxane, which has α2-antagonistic activity and the inhibitory effect of clonidine was attenuated by 10 μM yohimbine. Moreover, the inhibitory effects of clonidine and tizanidine were also blocked by a small dose of prazosin, an antagonist for α1- and α2B-receptors. None of the antagonists had any effect on release of substance P, when given alone. These results suggest that α2B-adrenoceptors are involved in the inhibitory effects of clonidine and tizanidine on the release of substance P.

Original languageEnglish
Pages (from-to)585-589
Number of pages5
JournalNeuropharmacology
Volume30
Issue number6
DOIs
StatePublished - 1991

Fingerprint

Adrenergic Antagonists
Clonidine
Substance P
Spinal Cord
Piperoxan
Veratridine
Yohimbine
Prazosin
Adrenergic Receptors
tizanidine

Keywords

  • clonidine
  • prazosin
  • spinal cord
  • substance P release
  • tizanidine
  • yohimbine

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by α-adrenergic receptor antagonists. / Ono, H.; Mishima, A.; Ono, S.; Fukuda, H.; Vasko, Michael.

In: Neuropharmacology, Vol. 30, No. 6, 1991, p. 585-589.

Research output: Contribution to journalArticle

@article{2383e52cd5ed42668b05654d64a59dba,
title = "Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by α-adrenergic receptor antagonists",
abstract = "Effects of clonidine and tizanidine, which have antinociceptive and α2-agonistic actions, were studied on the release of substance P from slices of spinal cord from the rat. Veratridine-evoked depolarization induced a 2-3-fold increase in the release of substance P from the slices of spinal cord. Exposure of the cord tissue to 10 μM clonidine and tizanidine significantly reduced the release of substance P. The inhibitory effects of clonidine and tizanidine were attenuated by pre-exposure of the tissue to 10 μM piperoxane, which has α2-antagonistic activity and the inhibitory effect of clonidine was attenuated by 10 μM yohimbine. Moreover, the inhibitory effects of clonidine and tizanidine were also blocked by a small dose of prazosin, an antagonist for α1- and α2B-receptors. None of the antagonists had any effect on release of substance P, when given alone. These results suggest that α2B-adrenoceptors are involved in the inhibitory effects of clonidine and tizanidine on the release of substance P.",
keywords = "clonidine, prazosin, spinal cord, substance P release, tizanidine, yohimbine",
author = "H. Ono and A. Mishima and S. Ono and H. Fukuda and Michael Vasko",
year = "1991",
doi = "10.1016/0028-3908(91)90077-O",
language = "English",
volume = "30",
pages = "585--589",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by α-adrenergic receptor antagonists

AU - Ono, H.

AU - Mishima, A.

AU - Ono, S.

AU - Fukuda, H.

AU - Vasko, Michael

PY - 1991

Y1 - 1991

N2 - Effects of clonidine and tizanidine, which have antinociceptive and α2-agonistic actions, were studied on the release of substance P from slices of spinal cord from the rat. Veratridine-evoked depolarization induced a 2-3-fold increase in the release of substance P from the slices of spinal cord. Exposure of the cord tissue to 10 μM clonidine and tizanidine significantly reduced the release of substance P. The inhibitory effects of clonidine and tizanidine were attenuated by pre-exposure of the tissue to 10 μM piperoxane, which has α2-antagonistic activity and the inhibitory effect of clonidine was attenuated by 10 μM yohimbine. Moreover, the inhibitory effects of clonidine and tizanidine were also blocked by a small dose of prazosin, an antagonist for α1- and α2B-receptors. None of the antagonists had any effect on release of substance P, when given alone. These results suggest that α2B-adrenoceptors are involved in the inhibitory effects of clonidine and tizanidine on the release of substance P.

AB - Effects of clonidine and tizanidine, which have antinociceptive and α2-agonistic actions, were studied on the release of substance P from slices of spinal cord from the rat. Veratridine-evoked depolarization induced a 2-3-fold increase in the release of substance P from the slices of spinal cord. Exposure of the cord tissue to 10 μM clonidine and tizanidine significantly reduced the release of substance P. The inhibitory effects of clonidine and tizanidine were attenuated by pre-exposure of the tissue to 10 μM piperoxane, which has α2-antagonistic activity and the inhibitory effect of clonidine was attenuated by 10 μM yohimbine. Moreover, the inhibitory effects of clonidine and tizanidine were also blocked by a small dose of prazosin, an antagonist for α1- and α2B-receptors. None of the antagonists had any effect on release of substance P, when given alone. These results suggest that α2B-adrenoceptors are involved in the inhibitory effects of clonidine and tizanidine on the release of substance P.

KW - clonidine

KW - prazosin

KW - spinal cord

KW - substance P release

KW - tizanidine

KW - yohimbine

UR - http://www.scopus.com/inward/record.url?scp=0025891607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025891607&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(91)90077-O

DO - 10.1016/0028-3908(91)90077-O

M3 - Article

VL - 30

SP - 585

EP - 589

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 6

ER -